DexCom (Germany) Performance
| DC4 Stock | EUR 61.91 0.26 0.42% |
On a scale of 0 to 100, DexCom holds a performance score of 10. The firm shows a Beta (market volatility) of 0.6, which means possible diversification benefits within a given portfolio. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. Please check DexCom's value at risk, downside variance, and the relationship between the maximum drawdown and potential upside , to make a quick decision on whether DexCom's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, DexCom reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 4:1 | Last Split Date 2022-06-13 |
1 | Morgan Stanley, Truist Cautious on DexCom Cites Weaker Gross Margins, Modest Q3 Beat - Finviz | 11/25/2025 |
2 | DexCom Stock Trades Down, Here Is Why - Yahoo Finance | 01/08/2026 |
3 | DexCom Releases Preliminary, Unaudited Results for Q4 2025 - Yahoo Finance UK | 01/14/2026 |
4 | Dexcom releases preliminary, unaudited results for Q4 2025 - MSN | 01/19/2026 |
5 | New DexCom CEO Remains Focused on Addressing Recent Quality Issues - Morningstar | 01/23/2026 |
6 | Strs Ohio Sells 14,796 Shares of DexCom, Inc. DXCM - MarketBeat | 01/26/2026 |
7 | Price Over Earnings Overview DexCom - Sahm | 01/29/2026 |
8 | A Look Into DexCom Incs Price Over Earnings - Sahm | 02/06/2026 |
9 | Dexcom Inc Beats Q4 Profit Estimates Despite Revenue Shortfall - ChartMill | 02/12/2026 |
10 | Dexcom Stock After Volatility Is This High-Growth Medtech Now Mispriced - AD HOC NEWS | 02/17/2026 |
DexCom |
DexCom Relative Risk vs. Return Landscape
If you would invest 5,405 in DexCom Inc on November 26, 2025 and sell it today you would earn a total of 812.00 from holding DexCom Inc or generate 15.02% return on investment over 90 days. DexCom Inc is currently producing 0.2529% returns and takes up 1.9958% volatility of returns over 90 trading days. Put another way, 17% of traded stocks are less volatile than DexCom, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DexCom Target Price Odds to finish over Current Price
The tendency of DexCom Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 61.91 | 90 days | 61.91 | about 9.03 |
Based on a normal probability distribution, the odds of DexCom to move above the current price in 90 days from now is about 9.03 (This DexCom Inc probability density function shows the probability of DexCom Stock to fall within a particular range of prices over 90 days) .
DexCom Price Density |
| Price |
Predictive Modules for DexCom
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DexCom Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.DexCom Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. DexCom is not an exception. The market had few large corrections towards the DexCom's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold DexCom Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of DexCom within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | 0.60 | |
σ | Overall volatility | 3.04 | |
Ir | Information ratio | 0.12 |
DexCom Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DexCom for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DexCom Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| DexCom Inc is unlikely to experience financial distress in the next 2 years | |
| DexCom Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Dexcom Stock After Volatility Is This High-Growth Medtech Now Mispriced - AD HOC NEWS |
DexCom Fundamentals Growth
DexCom Stock prices reflect investors' perceptions of the future prospects and financial health of DexCom, and DexCom fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DexCom Stock performance.
| Return On Equity | 0.35 | ||||
| Return On Asset | 0.0889 | ||||
| Profit Margin | 0.18 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 23.31 B | ||||
| Shares Outstanding | 384.86 M | ||||
| Price To Earning | 191.84 X | ||||
| Price To Book | 10.31 X | ||||
| Price To Sales | 5.20 X | ||||
| Revenue | 4.66 B | ||||
| Gross Profit | 2.8 B | ||||
| EBITDA | 1.16 B | ||||
| Net Income | 836.3 M | ||||
| Cash And Equivalents | 1.38 B | ||||
| Cash Per Share | 15.11 X | ||||
| Total Debt | 3.59 B | ||||
| Debt To Equity | 159.90 % | ||||
| Book Value Per Share | 6.03 X | ||||
| Cash Flow From Operations | 1.44 B | ||||
| Earnings Per Share | 1.77 X | ||||
| Total Asset | 6.34 B | ||||
| Retained Earnings | 2.43 B | ||||
About DexCom Performance
By analyzing DexCom's fundamental ratios, stakeholders can gain valuable insights into DexCom's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DexCom has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DexCom has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.Things to note about DexCom Inc performance evaluation
Checking the ongoing alerts about DexCom for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DexCom Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DexCom Inc is unlikely to experience financial distress in the next 2 years | |
| DexCom Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Dexcom Stock After Volatility Is This High-Growth Medtech Now Mispriced - AD HOC NEWS |
- Analyzing DexCom's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DexCom's stock is overvalued or undervalued compared to its peers.
- Examining DexCom's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DexCom's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DexCom's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DexCom's stock. These opinions can provide insight into DexCom's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |